Low-intensity extracorporeal shockwave therapy for Peyronie's disease: An Indian experience. [PDF]
Maiti K, Srivastava SK, Pal DK.
europepmc +1 more source
Inhibition of phosphodiesterases 1 and 4 prevents myofibroblast transformation in Peyronie's disease. [PDF]
Harding SL +4 more
europepmc +1 more source
Measurement of Oxidative Stress Index in 102 Patients with Peyronie's Disease. [PDF]
Paulis G +3 more
europepmc +1 more source
Penile Traction Therapy for Peyronie's Disease: A Contemporary Narrative Review of Clinical Evidence and Evolving Trends. [PDF]
Gopi P +8 more
europepmc +1 more source
Intralesional Platelet-Rich Plasma for Treating Chronic Peyronie's Disease: A Single-Center Retrospective Cohort Study. [PDF]
Pucci L +9 more
europepmc +1 more source
Global Perspective on the Management of Peyronie's Disease. [PDF]
Moisés da Silva GV +3 more
europepmc +1 more source
A review of Peyronie's disease insurance coverage. [PDF]
Hricz N +7 more
europepmc +1 more source
Local and Systemic Effects of Chronic Intracavernous Injection of Papaverine, Prostaglandine E1 and Saline in Primates [PDF]
Aboseif, Sherif R. +7 more
core
Comparison of long-term patient reported outcomes of excisional and incisional corporoplasties for Peyronie's disease. [PDF]
Preece PD, Sahdev V, Davis PG, Rees RW.
europepmc +1 more source

